 |
|
 |
 |

Home > Company Index > Health Products & Services > Medical Appliances & Equipment > Endocardial Solutions, Inc.
 |
Endocardial Solutions, Inc. |
 |
 |
 |
PROFILE |
 |
Endocardial Solutions, Inc. (ESI) designs and manufactures a minimally invasive system for diagnosing tachycardia, a potentially fatal arrhythmia. The company's EnSite catheters and clinical workstations (together, the EnSite system) produce a high-resolution, real-time, three-dimensional color display of electrical activity in the heart chamber, thus allowing electrophysiologists to locate and diagnose tachycardia in real-time, and to determine the best course of treatment. Twin Cities neighbor Medtronic, which owns a stake in ESI, has distribution rights to the EnSite system in Europe and Japan. ESI sells its system in the US through a direct sales force.
COMPETITION |
 |
Boston Scientific Corporation (BSX)
Cardiac Pathways Corporation (CPWY)
Cardima, Inc. (CRDM)
|
 |
STOCK ANALYSIS |
 |
FURTHER ANALYSIS
Advanced Charting
Deals
FINANCIAL OVERVIEW |
 |
Fiscal Year-End: December
2000 Sales (mil.): 14.60
1-Yr. Sales Growth: 52.1%
Employees: 136
Revenue per employee: $107,352.94
KEY PEOPLE |
 |
James W. Bullock
CEO
Leota L. Pearson
CFO
CONTACT INFO |
 |
1350 Energy Ln., Ste. 110
St. Paul, MN 55108
US
Phone: 651-644-7890
Fax: 651-644-7897
Online: Web Site
|
 |
 |
 |
|
Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.
|

|
 |
 |
|
 |